Search results for "Coronavirus"
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
COVID-19 research looks at aspirin, disparities, long-term outcomes
Recent aspirin use may be associated with improved COVID-19 outcomes, and hospitals had widely differing mortality rates in April 2020. Half of discharged patients reported ongoing symptoms at four months, and most ICU patients showed evidence of impairments at one month, new studies found.
https://immattersacp.org/weekly/archives/2021/03/23/1.htm
23 Mar 2021
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
Primary care's role in COVID-19 vaccination
Patients report that they trust their primary care practitioner the most, because a physician can address their problems in a real, personal way.
https://immattersacp.org/archives/2021/04/primary-cares-role-in-covid-19-vaccination.htm
1 Apr 2021
Postdischarge COVID-19 studies find benefits of home oxygen, risks of PTSD, medical complications
Recent studies focused on patients' status after hospitalization for COVID-19, one finding that outcomes with home oxygen were good, but others noting that post-traumatic stress disorder (PTSD), readmissions, and new diagnoses of medical conditions were common.
https://immattersacp.org/weekly/archives/2021/04/06/2.htm
6 Apr 2021
Research on COVID-19 vaccines' duration, reactions, prioritization
Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021
Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021
Many recent studies reporting on COVID-19 vaccines' safety, effectiveness
New studies looked at the safety of the adenovirus COVID-19 vaccines, the effectiveness of almost all the vaccines, and the impacts of COVID-19 infection in pregnancy and on long-term cardiac function. A physician columnist addressed pandemic-related anger.
https://immattersacp.org/weekly/archives/2021/05/11/1.htm
11 May 2021
Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection
Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
https://immattersacp.org/weekly/archives/2021/05/18/1.htm
18 May 2021
Next ACP, Annals of Internal Medicine COVID-19 forum to focus on persistent symptoms
A virtual live event on June 9 will feature a panel of experts discussing current information on treating patients with persistent symptoms following acute SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2021/05/25/2.htm
25 May 2021